tiprankstipranks
Trending News
More News >

Eloxx Pharmaceuticals Delays Quarterly Report Filing

Story Highlights
Eloxx Pharmaceuticals Delays Quarterly Report Filing

Eloxx Pharmaceuticals ( (ELOX) ) has released a notification of late filing.

Don’t Miss TipRanks’ Half-Year Sale

Eloxx Pharmaceuticals has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The primary reason for this delay is the company’s ongoing financial constraints, which have prevented it from engaging an independent public accounting firm to review its unaudited financial statements. Eloxx Pharmaceuticals has not provided a specific timeline for when the delayed report will be filed. The company has indicated that there will be significant changes in its financial results, including an increase in net loss and accumulated deficit for the first quarter of 2025 compared to the same period in 2024. Additionally, there is substantial doubt about the company’s ability to continue as a going concern due to insufficient cash resources. The notification was signed by Sumit Aggarwal, President and CEO, on May 15, 2025, as part of the company’s ongoing compliance efforts.

More about Eloxx Pharmaceuticals

Average Trading Volume: 225

Technical Sentiment Signal: Strong Sell

Current Market Cap: $314

Find detailed analytics on ELOX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1